Genmab ($GMAB) used two of oncology’s biggest scientific stages—ASCO 2026 and the EHA 2026 Congress—to map out an aggressive expansion plan for its cancer portfolio, highlighting new data around its bispecific antibody...

IREN Limited ($IREN) is accelerating a strategic pivot away from Bitcoin (BTC) mining and toward AI-focused data center infrastructure, a shift investors increasingly view as a bid for more predictable, contract-driven...

Incyte ($INCY) reported positive Phase 3 results suggesting its tafasitamab plus lenalidomide combination added to standard R-CHOP chemotherapy could meaningfully improve first-line outcomes for ‘high-risk’ diffuse large...

Michael Saylor has introduced a new set of Bitcoin treasury metrics for Strategy (NASDAQ: MSTR), formerly MicroStrategy, as investors and analysts debate whether the companys aggressive leverage strategy can continue...

Investors are closely monitoring crypto stocks ahead of the Federal Reserves June 17, 2026, policy decision, with MicroStrategy (MSTR), Bitmine Immersion Technologies (BMNR), and Coinbase (COIN) emerging as key names to...

Fifteen years ago, on June 14, 2011, WikiLeaks made a decision that would become a landmark moment in Bitcoin history. By officially accepting Bitcoin donations, the whistleblowing organization demonstrated the real-world...

BitMine Immersion Technologies ($BMNR) is escalating its Ethereum-heavy treasury pivot after disclosing a combined crypto-and-cash reserve valued at roughly $9.6 billion, a stockpile anchored by more than 5.5 million Ether...

Shares of IREN ($IREN) climbed on Tuesday ET after the Australia-based AI infrastructure firm disclosed a large, Microsoft-linked GPU financing arrangement and outlined accelerated buildout plans tied to next-generation...

Alliance co-founder Imran Khan has raised concerns about the potential impact of Kalshis newly launched crypto perpetual futures products, suggesting they could reduce liquidity across decentralized finance (DeFi)...

Canadian entrepreneur and investor Kevin OLeary has defended SpaceXs massive valuation following the companys historic Nasdaq debut, arguing that investors are paying for its future potential rather than its current...